Therefore, in this study, we first examined TLR3 status in CCA cases and evaluated its association with clinicopathological parameters of the individual patients in order to search for a novel therapeutic target and also gain a better understanding of TLR3 signaling for improvement of therapeutic approaches targeting TLR3 with TLR3 ligands. The gene discussed is TLR3; the disease is cholangiocarcinoma.